Novel Treatment of Small-Cell Neuroendocrine of the Vagina

BACKGROUND: Primary vaginal small-cell neuroendocrine carcinoma is an extremely rare and highly aggressive malignancy. Eighty-five percent of patients die within one year of diagnosis from metastatic disease despite multimodal therapy. Gene expression profiling of tumor tissue may be useful for trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostamo, Kathryn, Peart, Mishka, McKenzie, Nathalie, Holloman, Conisha, Carlan, S. J., Ge, Li, Maksem, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817301/
https://www.ncbi.nlm.nih.gov/pubmed/29535879
http://dx.doi.org/10.1155/2018/9157036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817301/
https://www.ncbi.nlm.nih.gov/pubmed/29535879
http://dx.doi.org/10.1155/2018/9157036

Ejemplares similares